# Hello Heart

> Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.

- **Founded:** 2013
- **Headquarters:** Menlo Park, California, USA
- **Founders:** Maayan Cohen (Co-founder & CEO), Ziv Meltzer (Co-founder)
- **Team size:** ~420 employees
- **Products:** Hello Heart Mobile App, Connected Blood Pressure Monitor, Smart Pill Box, Nia - AI Heart Health Assistant, Employer & Health Plan Solutions
- **Notable:** 84% of high-risk members reduced blood pressure over 3 years (JAMA study of 28,000+ participants), Average 21 mmHg reduction in systolic blood pressure over 3 years among high-risk users, Published peer-reviewed outcomes in JAMA, Journal of the American Heart Association, and Value in Health

## Products & services

- **Hello Heart Mobile App** — AI-powered iOS and Android app that tracks blood pressure, pulse, cholesterol, weight, activity, and medications. Provides instant explanations of health metrics, personalized behavioral coaching tips, and daily reminders. Available free through participating employers, health plans, and Medicare Advantage programs.
- **Connected Blood Pressure Monitor** — FDA-cleared Bluetooth blood pressure monitor that pairs with the Hello Heart app to automatically log and analyze readings in real time.
- **Smart Pill Box** — Connected medication reminder device that integrates with the app to improve medication adherence for heart-related prescriptions.
- **Nia - AI Heart Health Assistant** — Launched October 2025, Nia is described as the world's first AI heart health assistant, designed to transform how people manage and understand their cardiovascular health through conversational AI.
- **Employer & Health Plan Solutions** — B2B platform sold to employers, health plans, Medicare Advantage plans, and government organizations. Includes program management, clinical reporting, and ROI analytics showing medical cost reductions.

## Achievements

- 84% of high-risk members reduced blood pressure over 3 years (JAMA study of 28,000+ participants)
- Average 21 mmHg reduction in systolic blood pressure over 3 years among high-risk users
- Published peer-reviewed outcomes in JAMA, Journal of the American Heart Association, and Value in Health
- $1,709 average annual medical cost savings per enrolled user (peer-reviewed, Value in Health)
- $4,014 annual savings per Medicare Advantage participant age 65+
- Validated Provider designation from the Validation Institute
- Member of American Heart Association's Innovators' Network
- Strategic collaboration with American College of Cardiology
- Deployed at 150+ Fortune 500 companies and government organizations
- Launched Nia, described as the world's first AI heart health assistant (October 2025)
- Equal clinical outcomes across race, age, and language groups - health equity milestone

## Latest updates

- **2025-10** — Launched Nia, the world's first AI heart health assistant, to transform conversational cardiovascular care
- **2025-08** — North Carolina State Health Plan added Hello Heart as a benefit for rural members
- **2025-04** — New independent study showed employers experienced average $1,434 medical cost reduction per member per year for Hello Heart participants
- **2024-10** — Appointed Bill Otten as Commercial President; expanded into government markets across the United States
- **2024-10** — Amwell expanded partnership to include Hello Heart in clinical programs portfolio on Amwell Converge platform
- **2024-08** — Launched symptom tracking feature for proactive heart health monitoring
- **2024-05** — Peer-reviewed study in Journal of the American Heart Association demonstrated reductions in blood pressure, cholesterol, and weight
- **2022-05** — Closed $70M Series D funding round led by Stripes to fuel growth in employer and health plan markets
- **2021-06** — Completed $45M Series C investment led by IVP (Insight Partners)
- **2021-10** — JAMA study of 28,000+ participants published, validating 84% blood pressure reduction rate over 3 years

## Links

- Website: https://helloheart.com
- LinkedIn: http://www.linkedin.com/company/helloheart
- Twitter/X: https://twitter.com/HelloHeartApp
- Instagram: https://www.instagram.com/helloheartapp/
- Facebook: https://www.facebook.com/HelloHeartAp

---

Profile page: https://yespress.io/hello-heart
Published by YesPress — https://yespress.io
Last updated: 2026-05-29